SOURCE: Industrial Info Resources
SUGAR LAND, TX--(Marketwire - Dec 5, 2012) - Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- Before the doors close on 2012, the North American Pharmaceutical & Biotech Industry is on track to wrap up nearly $16 billion worth of capital and MRO (maintenance) investments. Spread over 716 individual projects, this figure covers all the projects scheduled for completion from January 1, 2012, through December 31, 2012. While some of the large projects started construction this year, others began years ago. With projects reported for both the manufacturing and research sectors, the 2012 number represents a small increase of 31 projects, or 5%, over 2011, when 685 projects were completed.
For details, view the entire article by subscribing to Industrial Info's Premium Industry News at http://www.industrialinfo.com/showAbstract.jsp?newsitemID=231715&refer=mw, or browse other breaking industrial news stories at www.industrialinfo.com.
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, and eight offices outside of North America, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the www.industrialinfo.com "Contact Us" page.